Laanani M, Viallon V, Coste J, Rey G
Popul Health Metr. 2023; 21(1):21.
PMID: 38098030
PMC: 10722743.
DOI: 10.1186/s12963-023-00320-y.
Jeong S, Kim S, Lee D, Park E, Jang S
BMC Psychiatry. 2022; 22(1):341.
PMID: 35581575
PMC: 9115980.
DOI: 10.1186/s12888-022-03990-4.
Kucuker M, Almorsy A, Sonmez A, Ligezka A, Camsari D, Lewis C
Front Hum Neurosci. 2021; 15:660926.
PMID: 34248523
PMC: 8267816.
DOI: 10.3389/fnhum.2021.660926.
Nuebling G, Butzhammer E, Lorenzl S
Front Neurol. 2021; 12:656599.
PMID: 33790854
PMC: 8005587.
DOI: 10.3389/fneur.2021.656599.
Du J, Liu X, Zhou X, Wang H, Zhou W, Jiang J
Parkinsons Dis. 2020; 2020:8091963.
PMID: 33062248
PMC: 7537696.
DOI: 10.1155/2020/8091963.
Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.
Weintraub D
Neurotherapeutics. 2020; 17(4):1511-1524.
PMID: 32514891
PMC: 7851231.
DOI: 10.1007/s13311-020-00875-w.
Suicidal risk and demoralization in Parkinson disease.
Elfil M, Ahmed N, Alapati A, Bahekar R, Kandil M, Kim C
J Neurol. 2019; 267(4):966-974.
PMID: 31802218
DOI: 10.1007/s00415-019-09632-2.
Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.
Scherbaum R, Hartelt E, Kinkel M, Gold R, Muhlack S, Tonges L
J Neurol. 2019; 267(4):954-965.
PMID: 31797086
DOI: 10.1007/s00415-019-09657-7.
Drug Choices and Advancements for Managing Depression in Parkinson's Disease.
Assogna F, Pellicano C, Savini C, Macchiusi L, Pellicano G, Alborghetti M
Curr Neuropharmacol. 2019; 18(4):277-287.
PMID: 31622207
PMC: 7327944.
DOI: 10.2174/1570159X17666191016094857.
The Neuropsychiatry of Parkinson Disease: A Perfect Storm.
Weintraub D, Mamikonyan E
Am J Geriatr Psychiatry. 2019; 27(9):998-1018.
PMID: 31006550
PMC: 7015280.
DOI: 10.1016/j.jagp.2019.03.002.
Suicide in Parkinson's disease.
Shepard M, Perepezko K, Broen M, Hinkle J, Butala A, Mills K
J Neurol Neurosurg Psychiatry. 2019; 90(7):822-829.
PMID: 30661029
PMC: 7187903.
DOI: 10.1136/jnnp-2018-319815.
Suicide in Parkinson's Disease.
Li W, Abbas M, Acharyya S, Ng H, Tay K, Au W
Mov Disord Clin Pract. 2018; 5(2):177-182.
PMID: 30363456
PMC: 6174449.
DOI: 10.1002/mdc3.12599.
Perceived Treatment Status of Fluctuations in Parkinson Disease Impacts Suicidality.
Hinkle J, Perepezko K, Mari Z, Marsh L, Pontone G
Am J Geriatr Psychiatry. 2018; 26(6):700-710.
PMID: 29609901
PMC: 5993611.
DOI: 10.1016/j.jagp.2018.01.005.
Hospital care for mental health and substance abuse conditions in Parkinson's disease.
Willis A, Thibault D, Schmidt P, Ray Dorsey E, Weintraub D
Mov Disord. 2016; 31(12):1810-1819.
PMID: 27943472
PMC: 5321632.
DOI: 10.1002/mds.26832.
Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?.
Du X, Pang T
Front Psychiatry. 2015; 6:32.
PMID: 25806005
PMC: 4353372.
DOI: 10.3389/fpsyt.2015.00032.
Psychiatric aspects of Parkinson's disease.
Grover S, Somaiya M, Kumar S, Avasthi A
J Neurosci Rural Pract. 2015; 6(1):65-76.
PMID: 25552854
PMC: 4244792.
DOI: 10.4103/0976-3147.143197.
Suicidal behavior among Turkish patients with Parkinson's disease.
Ozdilek B, Gultekin B
Neuropsychiatr Dis Treat. 2014; 10:541-5.
PMID: 24707180
PMC: 3971933.
DOI: 10.2147/NDT.S60450.
Anxiety and depression in Parkinson's disease.
Djamshidian A, Friedman J
Curr Treat Options Neurol. 2014; 16(4):285.
PMID: 24532378
DOI: 10.1007/s11940-014-0285-6.
Mood stability in Parkinson disease following deep brain stimulation: a 6-month prospective follow-up study.
Chopra A, Abulseoud O, Sampson S, Lee K, Klassen B, Fields J
Psychosomatics. 2013; 55(5):478-84.
PMID: 24360528
PMC: 4063889.
DOI: 10.1016/j.psym.2013.09.003.
Prominent psychiatric symptoms in patients with Parkinson's disease and concomitant argyrophilic grain disease.
Grau-Rivera O, Gelpi E, Rey M, Valldeoriola F, Tolosa E, Compta Y
J Neurol. 2013; 260(12):3002-9.
PMID: 24046066
DOI: 10.1007/s00415-013-7101-1.